Clinical trial
PF-00477736 Is Being Studied In Advanced Solid Tumors In Combination With…
NCT00437203 · Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00437203 |
|---|---|
| Title | PF-00477736 Is Being Studied In Advanced Solid Tumors In Combination With Chemotherapy With Gemcitabine |
| Official title | Phase I Study of PF-00477736 With Gemcitabine In Patients With Advanced Solid Malignancies |
| Lead sponsor | Pfizer, Industry |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Neoplasms |
| Intervention type | Drug |
| Interventions | PF-00477736, gemcitabine |
| Enrollment | 43 |
| Start date | Dec 1, 2006 |
| Primary completion | Apr 1, 2011 |
| Completion | Apr 1, 2011 |
| First posted | Feb 19, 2007 |
| Last update posted | Apr 3, 2012 |
| Countries | Australia, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: